Medika d.d. Stock Forecast for 2023 - 2025 - 2030

Updated on 04/23/2024

Stock Rating
14
Price Target
0.00€
Consensus
-
Downside
-100.00%
Analysts
0
Stock Rating
14
Downside
-100.00%
Analysts
0
Price Target
0.00€
-

Medika d.d. Fair Value Forecast for 2023 - 2025 - 2030

In the last year, Medika d.d.'s Price has seen a drop from 17.49€k to 0.00€ – a 100.00% decrease. In the next year, analysts are expecting an increase in Fair Value, predicting it will reach 0.00€ – an increase of 100.00%. The Medika d.d. forecast is for Fair Value to reach 0.00€ or grow by 100.00%.

2025 Fair Value Forecast
0.00€
2026 Fair Value Forecast
0.00€
2027 Fair Value Forecast
0.00€
2028 Fair Value Forecast
0.00€
2029 Fair Value Forecast
0.00€
2030 Fair Value Forecast
0.00€

Medika d.d. Revenue Forecast for 2023 - 2025 - 2030

In the last three years, Medika d.d.'s Revenue has seen a drop from 3.99€B to 745.79€M – a 81.31% decrease. In the next year, analysts are expecting an increase in Revenue, predicting it will reach 2.03€B – an increase of 172.81%. The Medika d.d. forecast is for Revenue to reach 9.67€B or grow by 1197.20%.

2024 Rev Forecast
2.03€B
2025 Rev Forecast
5.14€B
2026 Rev Forecast
12.19€B
2027 Rev Forecast
4.81€B
2028 Rev Forecast
5.37€B
2029 Rev Forecast
6.90€B
2030 Rev Forecast
9.67€B

Medika d.d. Dividend per Share Forecast for 2023 - 2025 - 2030

In the last two years, Medika d.d.'s Dividend per Share has grown, increasing from 1400.00€ to 1620.76€ – an increase of 15.77%. In the next year, 0 analysts estimate that Medika d.d.'s Dividend per Share will decrease by 9.08%, reaching 1473.59€. According to professional forecasts, in 2030, Medika d.d.'s Dividend per Share will decrease by 8.70%, reaching 1479.75€.

2023 DPS Forecast
1.47€k
2024 DPS Forecast
1.46€k
2025 DPS Forecast
1.44€k
2026 DPS Forecast
1.50€k
2027 DPS Forecast
1.49€k
2028 DPS Forecast
1.48€k
2029 DPS Forecast
1.47€k
2030 DPS Forecast
1.48€k

Medika d.d. Free Cash Flow Forecast for 2023 - 2025 - 2030

Medika d.d. EBITDA Forecast for 2023 - 2025 - 2030

In the last three years, Medika d.d.'s EBITDA has decreased from 119.30€M to 27.73€M – a 76.76% drop. The next year looks promising for Medika d.d., with analysts predicting EBITDA of 65.36€M – an increase of 135.70%. Over the next seven years, experts anticipate that Medika d.d.'s EBITDA will grow at a rate of 705.47%.

2024 EBITDA Forecast
0.07€B
2025 EBITDA Forecast
0.14€B
2026 EBITDA Forecast
0.29€B
2027 EBITDA Forecast
0.13€B
2028 EBITDA Forecast
0.14€B
2029 EBITDA Forecast
0.17€B
2030 EBITDA Forecast
0.22€B

Medika d.d. EBIT Forecast for 2023 - 2025 - 2030

In the last three years, Medika d.d.'s EBIT has decreased by 77.91%, going from 105.94€M to 23.40€M. For the next year, analysts are expecting EBIT to reach 57.56€M – an increase of 146.00%. Over the next seven years, experts predict that EBIT will grow by 823.75%.

2024 EBIT Forecast
0.06€B
2025 EBIT Forecast
0.13€B
2026 EBIT Forecast
0.28€B
2027 EBIT Forecast
0.12€B
2028 EBIT Forecast
0.13€B
2029 EBIT Forecast
0.16€B
2030 EBIT Forecast
0.22€B

Medika d.d. EPS Price Prediction Forecast for 2023 - 2025 - 2030

In the last year, Medika d.d.'s EPS has seen a drop from 1914.01€ to 0.00€ – a 100.00% decrease. In the next year, analysts are expecting an increase in EPS, predicting it will reach 0.00€ – an increase of 100.00%. The Medika d.d. forecast is for EPS to reach 0.00€ or grow by 100.00%.

2025 EPS Forecast
0.00€
2026 EPS Forecast
0.00€
2027 EPS Forecast
0.00€
2028 EPS Forecast
0.00€
2029 EPS Forecast
0.00€
2030 EPS Forecast
0.00€